Short Description High-consequence infectious diseases (HCIDs), such as Ebola and Marburg virus disease, are on the rise. Rwanda’s neighbouring countries, Democratic Republic of the Congo, Uganda, and Tanzania are facing recurrent HCID outbreaks, which pose a significant health threat to Rwanda. The country currently lacks high-level…
Short Description The project Go Africa 2021 aims at promoting WHO’s global action plan on Antimicrobial Resistance (AMR). AMR in Neisseria gonorrhoeae (NG) is a global public health threat. In the WHO African region, 11 million new infections are estimated each year. NG prevention, diagnostics and control remain a great…
Short Description The COVID-19 pandemic is exerting enormous pressure on health systems around the world. Following the 2014 West African Ebola outbreak, health systems strengthening activities and interventions received increased funding and gained prominence in Guinea and Sierra Leone. Germany has played a major role in responding to the Ebola…
Short Description Since 2016, the Bernhard Nocht Institute for Tropical Medicine has been working with the Global Health Protection Programme (AfroLabNet) in Nigeria, Benin and Guinea to strengthen stationary and mobile laboratory capacities on viral hemorrhagic fevers (VHFs) of the risk group 4 such as Lassa fever. The COVID-19 pandemic…
Short Description Few countries in Sub-Saharan Africa have surveillance systems for antimicrobial resistance (AMR), resulting in significant gaps in data pertaining to bacteria of public health relevance. In cooperation with TRICE, this project aims to enhance resistance diagnostics in project countries by introducing a blood culture diagnostic system. Aims of…
Short Description Health workforce is the key to health systems resilience. WHO describes a well-performing health workforce as “one that works in ways that are responsive, fair and efficient to achieve the best health outcomes possible, given available resources and circumstances”. In the current COVID-19 crisis, health care workers (HCWs)…
Short Description The current COVID-19 pandemic highlighted the importance of efficient and robust drug regulatory authorities to ensure healthy lives and well-being for all. Well-functioning regulatory systems ensure the quality, safety and efficacy of medicines and contribute to timely access to essential medical products. Resilient regulatory systems with well-functioning structures,…
Short Description The World Health Organization (WHO) has added Lassa fever to its Research and Development Blueprint priority disease list, which includes diseases with a potential to cause public health emergencies for which there are currently no vaccinations or safe treatment solutions. The Irrua Specialist Teaching Hospital…
Short Description CPA facilitates collaborative research on optimal use of anti-infective drugs as a means to combat antimicrobial resistance. The research projects under CPA will help fill important gaps in knowledge about locally-relevant, real-world hospital practice and ways in which scientific training on appropriate drug use may assist healthcare professionals…